在接受TAVI的大动脉狭窄患者中对PCI策略的比较分析:系统性审查和网络元分析
Parisa Fallahtafti1,2, Hamidreza Soleimani1, Pouya Ebrahimi1
1Tehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Clinical cardiology
|July 26, 2024
概括
透皮冠状动脉干预 (PCI) 在跨导管大动脉植入 (TAVI) 期间增加了早期死亡率和心肌梗塞. 在TAVI之后的PCI与更高的1年死亡率有关,这表明个性化的时间策略至关重要.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的大动脉狭窄症 (AS) 通常与冠状动脉疾病 (CAD) 共同存在.
- 过导管大动脉植入 (TAVI) 是严重AS的常见治疗方法.
- 在TAVI患有CAD的患者中,穿皮冠状动脉干预 (PCI) 的最佳时间尚不清楚.
研究的目的:
- 为了比较不同PCI计时策略的结果,在接受TAVI的严重AS和CAD患者中.
- 评估PCI时间对死亡率,心肌梗塞,中风和出血事件的影响.
主要方法:
- 进行了一个频率网络元分析.
- 他们比较了三种复血管化策略:TAVI期间的PCI,TAVI后的PCI和没有PCI.
- 分析的结果包括30天和1年的死亡率,心肌梗塞,中风,严重出血和心脏起器植入.
主要成果:
- 与没有PCI相比,在TAVI期间的PCI与30天和住院死亡率显著增加有关.
- 在TAVI期间的PCI也显示了30天心肌梗塞的更高率.
- 与其他策略相比,TAVI后的PCI与1年死亡率的增加有关.
结论:
- 在TAVI期间同时进行PCI似乎会使患有CAD的严重AS患者的早期结果恶化.
- 在TAVI之后的PCI增加了1年死亡率的风险.
- 个体化的患者特征和程序因素应指导PCI时间策略的选择.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


